Actual Medicinal Product (AMP) Colofac MR 200mg capsules (Sigma Pharmaceuticals Plc)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from moisture. Manufacturer recommends storing in original container. No stability data available.
- Provenance
-
This recommendation is based on the products Colofac 200mg MR capsules (Cooper Consumer Health B.V) and Mebeverine 200mg modified release capsules (Aspire Pharma Ltd).
- Generic
- Mebeverine
- Formulation
- Mebeverine 200mg modified-release capsules
-
Mebeverine
-
Mebeverine 200mg modified-release capsules
-
Colofac MR 200mg capsules (Sigma Pharmaceuticals Plc)
-
-
Mebeverine 100mg tablets